HQL
Tekla Life Sciences Investors
18.70$
+1.1%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.07 | 0.30 | 3.27 | 0.09 | -2.99 | 5.20 | 2.71 | -4.02 | 0.83 | 3.09 | 2.99 | |
| 0.22 | 0.29 | 0.24 | 0.22 | 0.21 | 0.19 | 0.20 | 0.23 | 0.22 | 0.19 | 0.19 | 0.17 | |
| -0.17 | -0.22 | 0.06 | 3.05 | 0.09 | -2.99 | 5.20 | 2.71 | -4.02 | 0.83 | 3.09 | 2.99 | |
| – | – | 0.00 | 0.00 | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| 0.24 | 0.31 | 0.25 | 0.05 | 0.25 | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 | 0.05 | 0.03 | |
| 4.65 | 1.99 | 0.64 | 0.06 | 0.25 | 0.05 | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | 0.03 | |
| -0.20 | -0.24 | -0.18 | -0.18 | -0.16 | -3.04 | 5.16 | 2.66 | -4.07 | 0.79 | 3.04 | 2.96 | |
| 4.90 | 2.30 | 0.39 | 3.39 | 1.44 | 2.92 | 0.00 | 0.00 | – | – | – | – | |
| 4.70 | 2.06 | -0.57 | 3.21 | 1.28 | -3.04 | 5.16 | 2.66 | -4.07 | 0.79 | 3.04 | 2.96 | |
| 4.90 | 2.30 | 1.27 | 0.00 | 0.00 | -0.12 | -0.09 | -0.17 | -0.12 | 0.79 | – | – | |
| 4.70 | 2.06 | -0.57 | 3.21 | 1.28 | -3.04 | 5.16 | 2.66 | -4.07 | 0.79 | 3.04 | 2.96 | |
| 9.59 | 4.35 | -0.97 | 3.21 | 2.72 | -3.04 | 5.16 | 2.66 | -4.07 | 0.79 | 3.11 | 2.96 |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.